Revolade 25 mg (14 Tablets)

Revolade 25 mg contains Eltrombopag Olamine, a thrombopoietin receptor agonist that helps increase platelet production in certain medical conditions.

 Indications:

• Chronic immune thrombocytopenia (ITP) in adults and children.

• Severe aplastic anemia.

• Thrombocytopenia related to chronic hepatitis C.

 Dosage Form:

• Pack contains 14 tablets of 25 mg each.

 Warnings:

• Use only under medical supervision.

• Avoid dairy products or iron/calcium supplements 2 hours before or after taking the drug.

• Regular blood and liver tests are recommended during treatment.